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Abstract 
Executive functioning (EF) represents a set of cognitive skills that are important for daily 
functioning. EF can be influenced by a number of biopsychosocial factors, many of which are 
present in the pediatric population (i.e., youth with at least one medical condition). It is important 
to understand EF in this population as it affects aspects of their physical health (e.g., treatment 
adherence). Previous meta-analyses have been conducted to examine EF in the pediatric 
population, and they have generally found deficits in EF compared to healthy peers. However, 
these previous meta-analyses have only focused on specific medical conditions (e.g., pediatric 
youth with cancer). To the author’s knowledge, there has never been a meta-analysis of EF in the 
pediatric population more broadly. The current study serves to begin the process of closing this 
gap in the literature. Publications on EF in pediatric youth with a medical condition (i.e., 
cancer/tumor, epilepsy/seizure, or diabetes) were collected and used in a meta-analysis. Findings 
suggest pediatric youth have lower EF compared to healthy peers as a whole, though differences 
between the illness groups were noted. The epilepsy/seizure literature report the largest EF 
deficits across the various EF skills, and the diabetes group only showed small (though clinically 
and statistically significant) deficits in the domain of planning/organization. These findings 
provide early evidence for the benefit of considering cross-illness factors when working with 
pediatric youth, and suggest this area warrants further study.  
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Introduction 
Executive functioning (or executive functions) has been an increasing focus of research 
in the field of psychology. It is believed to play a major role in the psychosocial and 
academic/work functioning of individuals, and has been found to be influenced by a myriad of 
different factors. Unfortunately, previous studies examining executive functioning have been 
inconsistent in their operationalization of executive functions (as detailed below), creating a need 
to aggregate the results in a helpful and meaningful way. Having a better understanding of 
executive functioning, pariticularly in populations most heavily impacted by executive 
functioning, can help set the stage for the development of widely applicable and efficacious 
interventions. 
There are many different ways executive functioning can be negatively affected in youth 
due to its overarching role and long lasting development. One population that is known to face 
many adversities is the pediatric population, or children who have at least one medical condition. 
While some studies have examined executive functioning in subgroups of this population, such 
as children with cancer (e.g., Christ, Moinuddin, McKinstry, DeBaun, & White, 2007; McNally, 
Rohan, Pendley, Delamater, & Drotar, 2010; Wolfe et al., 2013), our knowledge of executive 
functioning in the pediatric population more broadly is lacking. In order to better address 
executive functioning difficulties in pediatric youth, and help improve their long-term outcomes, 
it is important to gain a better understanding of just how executive functioning is impacted in the 
population. 
Executive Functioning 
 General information. “Executive functioning” represents a collection of individual 
cognitive skills that play a role in day-to-day functioning. Conceptually, executive functioning 
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(EF) represents the brain conducting second-level processing of basic sensory inputs. That is, at 
the “lower level” the brain processes information available through the senses individually. This 
information is then processed and integrated, which is the role of EF (Stuss, 1992). Therefore, 
EF mastery plays a significant role in how people understand and interact with their 
environment. 
 Unfortunately, comprehensive models of understanding EF are lacking. This is likely in 
part due to the disagreement about what can be classified as executive functions. As is discussed 
in more detail below, there has been research on individual components that influence EF, such 
as biology and development. Yet there is a need to understand EF within the context of various 
influencing factors, especially among populations that are uniquely subjected to EF challenges. 
While no comprehensive model exists, different researchers have conceptualized EF in 
various ways, with common skills including: inhibition, shifting attention, emotional control, 
initiation, working memory, planning/organizing, organization of materials, and self-monitoring 
(Gioia, Isquith, Guy, & Kenworthy, 2000). These skills can be consolidated in different ways as 
well, such as the Behavioral Regulation and Metacognition indices of the Behavior Rating 
Inventory of Executive Functioning (BRIEF; Gioia et al., 2000), or “cool” (i.e., cognitive) and 
“hot” (i.e., emotional) components (Brock, Rimm-Kaufman, Nathanson, & Grimm, 2009). 
 Some researchers have argued that these EF skills represent a single EF factor, which is 
supported by the high level of correlation among the skills (for a review, see Garon, Bryson, & 
Smith, 2008). However, others have also argued that the skills are all unique, as evidenced by 
factor analyses demonstrating the skills loading onto separate factors (Garon et al., 2008). More 
recently, models have suggested that the reality is a combination of the two, with the different 
skills being unique but highly correlated and dependent upon one another (Garon et al., 2008). In 
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support of this perspective, some past studies have found evidence that EF skills develop at 
different times (e.g., Stuss, 1992), potentially because later skills depend upon earlier skill 
development. 
 Development of EF skills occurs throughout childhood and adolescence, with signs of 
their development being present in preschool (Carlson & Wang, 2007) and improvement being 
measurable until at least 15 years of age (Best, Miller, & Naglieri, 2011). For youth, EF is a very 
important set of skills to develop due to its link to academic functioning (particularly “cool” EF; 
Best et al., 2011; Brock et al., 2009). A meta-analysis by Alvarez and Emory (2006) suggests 
that by adulthood EF skills are reliant on various pathways throughout the brain, suggesting all 
phases of brain development have implications for the development of EF. 
 Of note, there are two primary ways to assess EF: performance-based measures and 
rating scales/questionnaires. Previous research has suggested that these two types of 
measurement methods pick-up different underlying constructs (Toplak, West, & Stanovich, 
2013). Conceptually, questionnaires may identify more “real world” EF whereas performance-
based measures can help to assess specific targeted skills. Therefore, it is also possible to 
consolidate EF findings in these ways and it is helpful to examine EF performance across 
measurement types. 
 Longitudinal implications. EF has been thought to be an important set of skills for 
achievement in various facets of life throughout development. Beginning in early life, EF plays a 
role in how well students will perform in school. As Bull, Espy, and Wiebe (2008) state, “for 
children just entering school many of the tasks they are faced with are completely novel and as 
such may place particularly heavy demands on cognitive processes”(p.4) such as EF. To support 
this idea, it has been found that EF skill levels in preschool can predict future learning a few 
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years into grade school (Bull et al., 2008). Unfortunately, without intervention, EF deficits have 
been found to persist from childhood to young adulthood, at least in a sample of youth with 
Attention Deficit/Hyperactivity Disorder (ADHD; J. Biederman et al., 2007). Because the effects 
of EF deficits are long-term and pervasive, it is important to better understand what may lead to 
EF deficits (e.g., chronic medical conditions) so at-risk populations can be targeted. 
 Development. The development of EF is influenced by various psychosocial and 
biological factors. For example, parenting dimensions have been found to predict EF 
development, particularly support for autonomy (Bernier, Carlson, & Whipple, 2010). There has 
also been mixed evidence of single parenthood affecting EF development, though it is still 
unclear to what extent socioeconomic status (SES) confounds this relationship (Sarsour et al., 
2011). Language may play a role in EF development as well, though it is confounded with other 
aspects of the home environment (Sarsour et al., 2011). In at least one study, temperamental 
reactivity and financial stressors were found to interact when predicting future EF in young 
children (Raver, Blair, & Willoughby, 2013). In a summary of how EF can be developmentally 
affected by a number of psychosocial components, Ylvisader and Feeney (2002) wrote the 
following:  
“a variety of distinct research strategies converge on the following developmental 
themes: executive self-regulation of behaviour begins early in infancy, develops slowly, 
continues to develop through adolescence, can be facilitated with well conceived 
supports, and is variable in relation to context (domain of content and setting), 
motivation, and cultural values” (p. 57). 
Biologically, EF has been historically associated with the Prefrontal Cortex (PFC). 
However, this view is no longer held by many, as there is growing evidence that the PFC 
6 
interacts with many other areas of the brain in regards to EF (Alvarez & Emory, 2006; Stuss, 
1992). Because EF relies on many areas of the brain, it is believed that the development of 
different skills at different times of life is in part due to the differential development of the brain 
(Stuss, 1992). The consequence of this relation to brain development is that EF skills are 
theoretically vulnerable to various brain insults throughout development, including from medical 
etiologies and treatments. 
 Correlates. EF has been studied extensively in relation to psychopathologies, particularly 
ADHD (Biederman et al., 2004). Children with ADHD have been found to have deficits in 
several EF skills compared to peers, though similar deficits have been found in other 
psychopathology groups (e.g., oppositional defiant disorder, conduct disorder, autism; Sergeant, 
Geurts, & Oosterlaan, 2002). More recently, this line of research has expanded more to include 
Posttraumatic Stress Disorder (PTSD) as well. Several studies have found traumatic experiences 
to be predictive of poorer executive functioning, including war-related (Polak, Witteveen, 
Reitsma, & Olff, 2012) and familial trauma (DePrince, Weinzierl, & Combs, 2009). These 
articles note that not all traumas are associated with poor EF outcomes, though they highlight the 
need to better understand how experiences may result in poor EF developmental trajectories. 
Pediatric Population  
As the literature demonstrates, EF is a set of important skills that can be influenced by an 
array of psychosocial and biological factors. The majority of the literature on EF thus far has 
focused on the general population, or medically healthy children with psychological disorders, 
and looked primarily at how a small set of factors influences EF (e.g., Fishbein et al., 2009; 
Garon et al., 2008). In summary, these studies have found that EF develops throughout childhood 
and adolescence, leaving it vulnerable to adversities such as low SES, parenting style, and 
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various other factors. However, it is unclear how EF may be influenced in a pediatric population 
that is atypical from the general population and is marked by a number of factors that are likely 
to affect EF development. These factors include reduced school attendance (Fowler, Johnson, & 
Atkinson, 1985; Kearney, 2008), exposure to medications with neurocognitive side effects (e.g., 
antiepileptics; Mitchell, Zhou, Chavez, & Guzman, 1993), reduced biological efficiency of EF 
pathways (e.g., corpus callosotomy in epilepsy), and high levels of psychosocial stress (Lavigne 
& Faier-Routman, 1992). 
The pediatric population represents youth who have at least one medical condition (e.g., 
diabetes, epilepsy, cancer). Research with youth in this population has found that many of the 
factors highlighted above as relevant for EF are impacted. The work that has been done thus far 
has focused on specific populations with specific medical conditions (e.g., cancer). This includes 
some previous meta-analyses regarding neurocognitive functioning within a specific condition. 
For example, Naguib, Kulinskaya, Lomax, and Garralda (2009) conducted a meta-analysis of 24 
studies examining neurocognitive functioning in pediatric youth with Type 1 diabetes and found 
overall reduced intellectual functioning. Another meta-analysis suggests that pediatric youth 
receiving chemotherapy for Acute Lymphoblastic Leukemia (ALL) have impairments in some 
aspects of EF (Peterson et al., 2008). While there have been some meta-analyses looking at 
pediatric populations more broadly (e.g., examining social competence; Martinez, Carter, & 
Legato, 2011), they have not examined EF. Therefore, there is a gap in the literature regarding 
EF in pediatric populations more broadly. 
Various medical conditions have different etiologies and prognoses, meaning the specific 
effects in regards to EF likely vary (especially since there are very few “common” medical 
conditions in pediatric youth, meaning there is a wide variety of conditions to consider; Pless & 
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Perrin, 1985). Nonetheless, deficits in EF broadly are being identified, with some of the 
predictors such as parenting, home environment, and trauma showing consistent relationships 
across a wide range of medical conditions. 
 Biological factors. There is a direct physiological component that needs to be taken into 
consideration when working with the pediatric population. As mentioned above, EF is primarily 
represented in the PFC of the brain, though it relies on other areas of the brain as well. Brain 
tumors are the second most common form of cancer in pediatric youth (Ward, DeSantis, 
Robbins, Kohler, & Jemal, 2014). These tumors, combined with the radiation of the brain and 
surgeries needed to treat them, cause damage to the brain tissue. This damage puts at least 
pediatric youth with cancer at risk of poor EF outcomes, which may partially explain the poor 
cognitive and academic outcomes that have been found in this population (Anderson, Godber, 
Smibert, Weiskop, & Ekert, 2000).  
However, cancer is not the only diagnosis with biological implications for EF. For 
example, Sickle Cell Disease (SCD) can lead to strokes in various areas of the brain, which may 
damage cortical tissue that is crucial for EF pathways and lead to potential EF challenges. In fact, 
SCD has been linked to deficits in ability to maintain attention, lowered intellectual functioning, 
and lowered academic skills (Bonner, Schumacher, Gustafson, & Thompson, 1999; Wang et al., 
2001). Spina bifida, a medical condition that directly affects the central nervous system (CNS), 
has also been associated with poorer EF outcomes compared to healthy controls (Burmeister et 
al., 2005). There is also evidence of reduced EF associated with epilepsy (MacAllister et al., 
2012), a medical condition marked by abnormal electrochemical patterns in the brain that can 
result in neuronal damage. 
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Finally, various chemicals may affect the CNS. This can include medications (e.g., 
chemotherapy; Copeland, Moore, Francis, Jaffe, & Culbert, 1996), but also effects of the 
condition itself. For example, deficits in EF have been found in pediatric youth who have 
hyperglycemic episodes related to diabetes (for a review, see Desrocher & Rovet, 2004) which 
can result in elevated levels of ketones. Therefore, pediatric youth have unique risk factors for 
EF development in regards to CNS function. 
Psychosocial factors. Medical conditions have far-reaching effects within a child’s 
socioecological network, which has implications for psychological wellbeing. Parenting stress 
(Cousino & Hazen, 2013) and parental monitoring (Ellis et al., 2007) are related to EF, and are 
affected by a child’s medical condition. Pediatric youth may have fewer opportunities to function 
as independently as their same-age peers, which has implications for their EF development (at 
least in early childhood; Bernier et al., 2010). In addition, many medical conditions found in the 
pediatric population have the potential to be traumatic. The mere diagnosis of a medical 
condition, particularly one that is associated with morbidity, can be traumatic for families 
(Landolt et al., 2002). The literature on these potentially traumatic events (PTEs) often refers to 
these traumas as Pediatric Medical Traumatic Stress (PMTS; Price, Kassam-Adams, Alderfer, 
Christofferson, & Kazak, 2016). It is possible that youth who experience more traumatic events 
related to their medical condition(s) may have worse EF outcomes. 
 Environmental factors. Finally, broader environmental variables linked to EF, such as 
low SES, are disproportionately relevant in the pediatric population compared to the general 
population. Low SES families are at a heightened risk of having poor health (e.g., via altered 
immunological processes; Miller, Chen, & Cole, 2009). The potential reasons for this are far-
reaching, and include lack of resources available to maintain health (e.g., food 
10 
availability/accessibility in a neighborhood affecting obesity rates; Rosenkranz & Dzewaltowski, 
2008). Not only can these factors lead to higher rates of medical conditions, but they have also 
been found to negatively affect EF development. For example, a study of kindergartners found 
that those from low SES families demonstrated lower performance on several EF tasks compared 
to middle class peers (Noble, Norman, & Farah, 2005). It has also been suggested that low SES 
leads to heightened stress levels, which may alter the stress response system in a way that 
negatively affects neurocognitive functioning (Hackman & Farah, 2009) and potentially physical 
health. Many environmental factors tend to affect and interact with one another, but as a whole 
they likely have a strong impact on development of EF skills for pediatric youth. A summary of 
these EF-related factors can be found in Figure 1. 
Implications. It is important to have a better understanding of EF in this population more 
broadly. Non-adherence to treatment regimens, which can have medical implications, is common 
within the pediatric population (La Greca & Mackey, 2009). This non-adherence may in part be 
due to EF deficits making it difficult for pediatric youth to comply. For example, pediatric youth 
with insulin-dependent diabetes often must complete calculations to determine the necessary 
insulin dose (with a formula that can change over time), and they need to estimate glucose 
content of food. This conceptually requires self-monitoring (to remember to check/calculate), 
sequencing abilities (to recall appropriate order of steps), planning/organization (to have 
everything ready in advance), inhibition (to limit snacking), and working memory (to complete 
the calculations). Indeed, two studies of pediatric youth with diabetes have found that higher EF 
was associated with better treatment adherence (Bagner, Williams, Geffken, Silverstein, & 
Storch, 2007; Perez et al., 2017). A third study found that youth-reported attention problems 
were associated with poorer diabetes regiment adherence (Turner, Berg, Butner, & Wiebe, 
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2018). Another similar study found evidence of EF influencing glycemic control through 
treatment adherence (McNally et al., 2010). In addition, EF challenges may help explain some of 
the difficulties that are seen in this population (e.g., poor performance on neuropsychological 
batteries compared to healthy classmates, potentially due to early EF challenges hindering 
progress in several academic domains; Noll et al., 2001). Only by understanding the extent of EF 
challenges in this population can we effectively target the deficits in treatment. 
In addition, it is important to understand EF within this population as a whole rather than 
examining EF for specific conditions. By getting a better understanding of whether or not there 
are common EF deficits across conditions, or potentially patterns of EF deficits in illness groups, 
we can more effectively generalize our treatments across illness groups. In the pediatric 
population, rare conditions are the norm rather than the exception (Pless & Perrin, 1985). 
Therefore, it is not feasible to assess EF for each illness separately. In addition, comorbid 
medical conditions are common (Newacheck & Stoddard, 1994). By having an understanding of 
the extent to which EF deficits are common (or vary) across conditions, clinicians can more 
confidently form effective assessment and intervention programs for a given pediatric patient 
even if no research has been done on the patient’s specific presentation of medical conditions. 
That being said, it is also not feasible to conduct a large study looking at the pediatric population 
as a whole. Therefore, it is important to identify a way to select initial conditions to study that 
can help to represent the pediatric population more broadly. One such way is based on level of 
Central Nervous System (CNS) involvement, which has been used to categorize multiple 
conditions in the past (e.g., Deidrick, Grissom, & Farmer, 2009). By examining conditions with 
varying degrees of CNS involvement, there can be more generalizable findings for the pediatric 
population more broadly. 
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Summary 
EF represents an important set of skills that play a significant role in day-to-day 
functioning and likelihood of future productivity and success. Pediatric youth with chronic 
medical conditions, who have many illness-related complications that can negatively impact EF 
development, are not well understood as a population in regards to EF. As mentioned above, 
some work has been done to examine EF in pediatric youth, with the focus primarily being on 
pediatric youth with specific conditions (e.g., McNally et al., 2010). This previous work can be 
used to create a preliminary conceptual model of EF in pediatric youth (Figure 1). Yet, there has 
never been a meta-analysis specific to EF in pediatric youth with chronic medical conditions as a 
whole, or comparing multiple medical conditions in the pediatric population.  
The current study seeks to begin the process of filling this gap in information by 
conducting a meta-analysis of EF in pediatric youth with chronic medical conditions that have 
varying degrees of CNS involvement (specifically: cancer/tumor, epilepsy/seizure, diabetes). In 
addition, different methods of measuring EF are assessed to help identify potential differences 
that have been found in other studies (e.g. Toplak et al., 2013). Doing so will help to further 
determine all of the relevant factors related to EF in pediatric youth, and can help inform EF 
treatments for these youth. The current study seeks to address the following hypothesis and 
research questions: 
Hypothesis/Research Questions 
1. Hypothesis: Pediatric youth with chronic medical conditions (i.e., cancer/tumor, 
epilepsy/seizure, diabetes) will have lower EF skills overall compared to healthy same-
age peers. 
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2. Research Question 1: Are children with particular medical conditions more likely to have 
deficits in EF?  
3. Research Question 2: Do EF patterns vary as a function of the format of EF measure 
used?  
Method 
Meta-Analysis 
The current study used a meta-analytic approach to address the primary hypothesis and 
research questions. Meta-analysis differs from other studies that examine a single set of data (i.e., 
primary or secondary analyses), and instead uses the results of various studies as data to be 
further analyzed (Card, 2012). A structured system was utilized to complete the literature review 
and abstraction of the relevant data from the publications, based on recommendations by Card 
(2012). The current study was also conducted in general compliance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; Moher, Liberati, 
Tetzlaff, & Altman, 2009) guidelines. 
Inclusion Criteria 
 In order to be included in the current study, published research needed to meet the 
following criteria: 
1. The samples used were exclusively comprised of children/adolescents (up to the age of 
19) at the time of assessment. 
2. Youth in the sample had at least one qualifying medical condition. Comorbid conditions 
were acceptable (though rarely represented in the literature). 
3. Analyses and results included information about pediatric youth compared to healthy 
same-age peers, in regards to EF.  
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a. In lieu of an included healthy control group, studies with standardized scores, or 
raw scores for assessments for which we had sufficient information from the 
normative sample, were permitted. 
4. The data were from independent samples. To the extent possible, studies with 
overlapping samples (e.g., multiple articles from a single overarching longitudinal study) 
were identified and only one set of measurements from a given measure with the sample 
were used. 
a. Multiple publications on the same sample were permitted, but only if there were 
not overlaps in the measures (e.g., if one publication reported scores for Digit 
Span while another reported scores for Rey Complex Figure). 
b. For longitudinal studies, the baseline timepoint was used by default. Exceptions to 
this included: 1) if EF measures were only used at a later timepoint, or 2) the 
baseline measurements were confounded in some way (e.g., immediately post-
intervention). 
5. The study utilized at least one formal neuropsychological assessment measure that 
included EF as a component. 
6. Sufficient information was reported to compute effect size. If there was insufficient data, 
authors were contacted (when possible) in an attempt to access the necessary information. 
7. The article was written in English. 
Literature Search 
 To identify as many publications as possible across databases, Google Scholar was used 
to conduct the searches for publications. This approach was chosen due to the wide variability to 
the fields, and thus databases, that studies regarding EF in pediatric youth are published within 
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(e.g., neurology, nursing, psychology). In addition, Google Scholar allowed for easier 
identification of a wider array of publication formats (e.g., dissertations, book chapters) than are 
often included in specific databases.  
Based on reviews of the publications identified via a preliminary search, the following 
keywords/phrases were used in various combinations to identify preliminary publications: 
pediatric, youth, children, adolescents, executive functioning, executive functions, inhibition, 
effortful control, switching, working memory, updating, selective attention, planning, organizing, 
neurocognitive, neuropsychological. For a full list of the exact search phrases used, see 
Appendix B. 
 Based on a preliminary search, different medical conditions were considered for the focus 
of the current study. After review of the amount of available literature and characteristics of 
conditions, three conditions were chosen to serve as initial representations of the larger pediatric 
population. Those conditions were epilepsy/seizure disorders (with direct CNS involvement), 
cancer/tumors (with direct and indirect CNS involvement), and diabetes (with indirect CNS 
involvement). Of note, like many other pediatric conditions these populations are not perfectly 
homogenous (e.g., blood vs. solid tumor cancers, malignant vs. benign tumors, partial vs. general 
epileptic seizures). Studies were included if they represented a sample that was considered to 
demonstrate the core signs/symptoms of the chosen medical conditions (e.g., epileptic brain 
activity or febrile seizures and not only psychogenic non-epileptic seizures) and if the 
signs/symptoms could not be explained by another medical condition (e.g., tumors related to 
neurofibromatosis were excluded from the cancer group).  
 The initial literature search was completed using Google Scholar, as detailed above. 
Publications that appeared potentially eligible based on title were downloaded and sorted based 
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on condition. The primary investigator then went through every publication and identified if each 
publication met the necessary eligibility criteria. Systematic reviews and other meta-analyses, 
though ineligible due to a lack of original data, were reviewed for additional publication 
references. Eligible publications that provided extensive literature reviews also had their 
reference sections reviewed for additional potential publications. Those publications were then 
also gathered and screened. Finally, all eligible publications then underwent forward citation 
searches via Google Scholar to identify more recent literature that may be eligible. Those 
publications were then added to the database and screened for eligibility. Any publications that 
lacked the necessary data for calculating effect sizes were flagged, and the corresponding authors 
were contacted (if contact details were available) to request the necessary data. As part of these 
requests, authors were asked to share any unpublished results they may have in order to limit the 
effect of publication bias. A summary of the literature search process can be found in Figure 2. 
These publication identification strategies were based on the suggestions of Card (2012). 
Publication tracking was handled in an EndNote database.  
Coding Procedure 
 Coding was primarily conducted within a Microsoft Access web database, which allowed 
for easy entry and data verification while allowing for easy export of the data for use in analyses. 
Given the format of the data, full double entry was not practical (e.g., many string variables, 
measure names that are sometimes represented by acronyms). Instead, a verification process was 
utilized, whereby one person completed initial entry of the information from a publication and a 
different person reviewed the entry and publication with the intent of identifying discrepancies. 
The primary investigator served as either the first person to enter the information from a 
publication, or as the person to verify an entry, for every publication in the database. Any 
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identified discrepancies were reviewed by the primary investigator and corrected as appropriate. 
The database was formatted in a way to allow for easy export to a Microsoft Excel spreadsheet, 
such that it could then be easily imported into the Comprehensive Meta-Analysis (CMA; 
Borenstein, Hedges, Higgins, & Rothstein, 2009) program for analyses.  
 Priority was given to entry of means, standard deviations, and subgroup sizes to allow for 
direct calculation of effect sizes in CMA. If necessary, t-test values, p-values, or Cohen’s d 
values were entered with the information that was included in the publication. After export to 
Microsoft Excel, normative sample information was added for those entries which required 
comparison to a pseudo-control group. In some cases, the necessary information could not be 
identified for a normative sample (e.g., raw scores reported in the publication but not in the 
manual for the measure, measures that allow raw score comparison between groups but have no 
normative data), thus those entries were removed from the database. Care was taken to ensure 
appropriate identification of normative sample information, either via the official manual for 
appropriate measures (e.g., WISC-IV; Wechsler, 2003), based on the correct version of the 
measure, or via referenced published norms for different versions of measures (e.g., translations) 
or variations of common measures (e.g., different versions of Stroop and continuous 
performance tasks). In addition, each set of scores was reviewed by the primary investigator to 
determine the EF skill best represented based on the measure/subtest used. The chair of the 
committee reviewed these EF skill assignments to establish a professional consensus. Based on 
commonly-used labels for various EF skills, and the range of skills represented, the following 
labels/groupings were utilized: inhibition, attention, planning/organization, switching, self-
monitoring, working memory/sequencing, initiate, and (for use with composites) a general 
category. 
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 Finally, the effect direction needed to be coded. That is, each set of comparisons was 
coded based on whether participants with a medical condition showed better or worse 
performance on the associated measure compared to the controls. This ensured data were 
appropriately represented in the analyses regardless of whether higher scores indicated better 
executive functioning (e.g., WISC Digit Span) or worse executive functioning (e.g., BRIEF 
GEC). For any ambiguous scores (e.g., scale conversions), the original publications were 
reviewed for indications of effect direction (e.g., mention of which group performed better, notes 
for tables). 
Statistical Analyses 
 The computation of effect sizes was handled by the CMA program. For standardized 
mean differences analyses, there are a few statistics to choose from. Cohen’s d (Cohen, 1987) is 
one of the more widely used variables calculated for meta-analyses. However, d has been found 
to be biased and to sometimes over-estimate the size of mean differences (Borenstein et al., 
2009). To correct for this bias, Hedges’s g applies a correction formula to d, which is thought to 
make the estimated effect size more accurate (Borenstein et al., 2009). Therefore, g was the 
primary statistic calculated for the purposes of this meta-analysis. Given the likelihood of 
unaccounted factors contributing to participant performance, a random effects model was used 
for all analyses (Card, 2012). 
 To answer the research questions, moderator variables were examined. CMA conducts 
these moderator analyses by running analyses by group (e.g., by publication format). Moderators 
of interest in the current study included: publication format, source of data (i.e., performance-
based measure or questionnaire), type of healthy control (i.e., included subsample or norms-
based pseudo-control), medical condition, and executive function skill.  
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 Finally, analyses were conducted to assess for potential publication bias and to estimate 
the robustness of the current findings. Specifically, a Failsafe N was calculated for all the 
significant results, as well as a funnel plot to assess for publication bias. Orwin’s Failsafe N 
(Orwin, 1983) was used to estimate how many non-significant results (i.e., findings of Hedges’s 
g = 0) would be needed for the results to fall below a threshold for a small effect size (i.e., 
Hedges’s g ≤ 0.2). Though imperfect (e.g., CMA calculates Orwin’s Failsafe N based on a fixed 
effects model), these analyses help provide additional context to the results and can help guide 
future research. 
Results and Analysis 
Search Outcome 
 The literature search yielded a total of 1,575 publications that were reviewed, of which 
314 publications representing approximately 25,063 participants (including those with medical 
conditions and any included healthy controls) met all inclusion criteria (see Figure 2). 
Unfortunately, not all publications provided demographic information regarding their samples. 
Out of the publications that provided information about gender (N = 276, 87% of publications), 
the gender split was relatively equal overall (MFemale% = 46.46). Only 30% of publications (N = 
96) reported information on race/ethnicity, with low representation of minority groups overall 
(MMinority% = 28.97). Mean age of participants was reported in 281 (89%) of the publications, 
with an overall average age of 11.09 years, and an age range of 1-19 years old. References for all 
eligible publications included in analyses can be found in Appendices E – G. Further information 
(e.g., measures for each publication used in analyses) can be found in Appendix H. 
A summary of reasons for ineligibility can be found in Figure 3. Of note, not all reasons 
for ineligibility were listed, only the most prominent. For example, a publication may have 
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focused on adults and may not have included any measures of EF, but in such cases each 
publication was labeled as ineligible due to whichever was identified first. Therefore, the 
representation of ineligibility should not be considered representative of the larger literature 
(e.g., the number identified as focused on adults does not encompass the total number of 
publications in the literature focused on adults).  
Statistical Results 
 Main analysis. First, to address the main hypothesis of the study, results comparing EF 
in pediatric youth to healthy controls was examined across all of the studies. A total of 1,624 
comparisons were made across all the publications. The overall results were found to be 
statistically significant with a moderate effect size (Hedges’s g = -0.473, 95% CI [-0.506, -
0.441]; Z = -28.50, p < .001), with pediatric youth demonstrating worse EF overall, supporting 
the main hypothesis. 
 To examine the results further and to address the first research question, the analyses 
were run separated by health condition (i.e., diabetes, cancer/tumor, epilepsy/seizure). The 
results remained statistically significant for each group, though differences were noted in effect 
sizes. Results representing pediatric youth with epilepsy/seizures showed the largest overall 
effect size (Hedges’s g = -0.558, 95% CI [-0.607, -0.509]; Z = -22.29, p < .001). In comparison, 
the cancer/tumor group showed a small-to-moderate effect size (Hedges’s g = -0.410, 95% CI [-
0.448, -0.372]; Z = -21.02, p < .001), while the diabetes group only showed a small overall effect 
size (Hedges’s g = -0.216, 95% CI [-0.370, -0.062]; Z = -2.76, p < .01).  
 Next, differences in specific EF skills were examined across the illness groups. For both 
cancer/tumor and epilepsy/seizure, all EF skills (i.e., inhibition, attention, planning/organization, 
switching, self-monitoring, working memory/sequencing, initiating) were found to be 
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statistically significantly lower than healthy peers. However, only planning/organization was 
found to be significantly lower than healthy peers for children with diabetes (Hedges’s g = -
0.780, 95% CI [-1.295, -0.265]; Z = -2.97, p < .01). A summary of all scores can be found in 
Table 1. 
 Finally, to address the second research question, analyses were run separately for each 
format of data collection (i.e., performance-based measure or questionnaire). Questionnaires 
were found to show a moderate effect size for differences in EF between pediatric youth and 
healthy peers (Hedges’s g = -0.554, 95% CI [-0.613, -0.495]; Z = -18.44, p < .001), while 
performance-based measures showed a small-to-moderate effect size (Hedges’s g = -0.437, 95% 
CI [-0.476, -0.399]; Z = -22.18, p < .001). This slight discrepancy is not surprising, as 
questionnaires generally ask about everyday EF which is more likely to include a mix of EF 
skills being used at one time compared to performance-based measures that attempt to isolate 
specific skills and provide structure that may make difficulties less apparent or pervasive. In 
addition, performance-based measures may better identify what children are best capable of 
achieving, while questionnaires may identify how well children actually perform when other 
factors are present (e.g., when in a busy classroom, during contentious arguments with 
caregivers). 
 Supplemental analyses. To further explore factors that may have contributed to the 
above results, additional moderators were examined. First, the use of included healthy controls 
was compared to the use of norms-based pseudo-controls. Overall, publications in each group 
demonstrated comparable moderate effect sizes when included controls were used (Hedges’s g = 
-0.427, 95% CI [-0.476, -0.377]; Z = -16.94, p < .001) or when pseudo-controls were used 
(Hedges’s g = -0.503, 95% CI [-0.545, -0.460]; Z = -23.26, p < .001). In addition, effect sizes 
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reported in different publication formats were all found to be statistically significant and 
generally in the moderate range. Specific values can be found in Table 2. 
 Source of data collection (i.e., performance-based measure or questionnaire) was further 
explored as a moderator. As discussed above, while use of performance-based measures can 
potentially provide more objective and focused assessment of EF skills without reporter bias, it 
could be argued that the structured neuropsychological setting may help scaffold EF skills in a 
way that helps performance. EF-related weaknesses could also potentially arise when multiple 
EF skills are needed at one time. Therefore, questionnaires asking about EF skills in daily life 
may provide additional insight that is not found in the neuropsychological assessment setting. 
For the cancer/tumor and epilepsy/seizure groups, both sources of data showed statistically 
significant deficits in EF compared to healthy peers, with small to moderate effect sizes for the 
cancer/tumor group (-0.385 and -0.453), and moderate to large effect sizes for the 
epilepsy/seizure group (-0.478 to -0.796). However, for the diabetes group, only performance-
based measures were found to be significant (Hedges’s g = -0.398, 95% CI [-0.581, -0.215]; Z = 
-4.265, p < .001) whereas questionnaires were non-significant (Hedges’s g = 0.135, 95% CI [-
0.130, 0.400]; Z = 0.998, ns). This difference was more pronounced when limited to only 
comparisons of planning/organization, with large effect found on performance-based tasks 
(Hedges’s g = -1.026, 95% CI [-1.588, -0.463]; Z = -3.573, p < .001) and non-significant results 
for questionnaires (Hedges’s g = 0.233, 95% CI [-0.728, 1.194]; Z = 0.476, ns). This discrepancy 
may reflect a tendency for parents to overestimate planning/organization abilities if the child’s 
medical condition is stable (suggesting good compliance) when other factors may contribute to 
that stability (e.g., parent support, partial functioning of the pancreas). A summary of these 
statistical results can be found in Table 3. 
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 Publication bias. To estimate the robustness of the above results, estimates of 
publication bias were conducted for all statistically significant findings. That is, funnel plots and 
a Failsafe N were examined for the overall database, for all publications of the cancer/tumor and 
epilepsy/seizures groups, and for the planning/organization comparisons for the diabetes group. 
Similar to the above analyses, funnel plots examining publication bias were conducted using a 
random effects model; the Failsafe N’s were calculated using a fixed effects model due to the 
requirements of the analysis software. A summary of the Failsafe N’s can be found in Table 4. 
 In the funnel plot for the entire database (Figure 4), values were found to be relatively 
evenly dispersed. There appears to be a slight bias for non-significant results showing worse 
performance by pediatric youth being included in the literature compared to non-significant 
results showing better performance. Orwin’s Failsafe N for the overall database estimates 1,685 
comparisons between pediatric youth and healthy peers where Hedges’s g = 0 would be 
necessary for the overall effect size to fall below 0.2, suggesting robust overall results. 
 When examining the funnel plot for the cancer/tumor group (Figure 5), a mild bias 
towards publication of poor performance by pediatric youth is evident. This finding may 
represent a tendency for published studies to focus on pediatric youth with more intensive forms 
of treatment (e.g., cranial radiation). However, despite this slight bias, Orwin’s Failsafe N for the 
cancer/tumor group estimated 414 comparisons where Hedges’s g = 0 would be necessary for the 
overall effect size to become clinically non-significant, suggesting the results would likely still 
remain significant even if the publication bias were not present.  
 For the epilepsy/seizure group, the funnel plot (Figure 6) suggests an opposite mild 
publication bias towards publication of findings where pediatric youth perform better than 
healthy peers. This may be a result of the many studies examining cognitive performance of 
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pediatric youth on antiepileptic medication, despite our efforts to use baseline pre-medication 
results when possible. Yet even with this mild publication bias, Orwin’s Failsafe N estimated an 
additional 1,552 findings of Hedges’s g = 0 would be necessary for the effect size to fall below 
the clinically meaningful threshold. Therefore, the results for the epilepsy/seizure population 
appear very robust. 
 Finally, the diabetes group demonstrated a slight bias towards publication of significantly 
poor performance (see Figure 7), at least for the publications specifically examining 
planning/organization ability. This may represent a tendency for the literature to focus on 
pediatric youth with episodes of more extreme glycemic levels (e.g., severe hypoglycemia and/or 
hyperglycemia). For calculating the Failsafe N, the threshold needed to be adjusted as the 
estimated Hedges’s g based on a fixed effects model (which is used for calculation of Orwin’s 
Failsafe N) was calculated to be -0.18, already below the threshold of -0.2 despite the random 
effects model estimating a Hedges’s g of -0.78. A lower threshold (i.e., -0.1) was subsequently 
used for the diabetes group. With that threshold, Orwin’s Failsafe N was calculated to only be 23 
despite the lower cut-off, suggesting these results should be interpreted with caution as additional 
research in this area may find overall clinically non-significant results. 
Discussion 
 At this time, there is no known “best practice” for assessing or treating executive 
dysfunction, particularly in pediatric youth. Having a more comprehensive understading of EF, 
especially in this population, will help to inform the development of additional treatments and 
can also allow for expanding upon previous intervention work in order to help increase efficacy, 
which has been called for in the literature (Butler et al., 2008). Along with having a better 
understanding of EF in pediatric populations that allows for better intervention creation, a 
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knowledge of patterns of deficits can allow for more targeted screening in pediatric youth. 
Although there may not be enough data available at this time to compare all of the EF domains 
across all chronic medical condition groups, the results of the current study provide a good start 
to this long-term research endeavor.  
 Overall, the results of the meta-analysis supported the primary hypothesis of this study, 
as pediatric youth with a chronic medical condition were found to have lower levels of EF in 
general compared to healthy peers. However, these results should be interpreted with care. Based 
on the comparison across illness groups (i.e., diabetes, cancer/tumor, epilepsy/seizure), a trend 
was noted for greater EF deficits with increasing levels of CNS involvement. That is, the 
diabetes group (with primarily indirect CNS involvement) showed only deficits in 
planning/organization. These findings could be a result of publication bias. The cancer/tumor 
group, with a mix of direct (e.g., brain tumor) and indirect (e.g., systemic chemotherapy for 
leukemia) CNS involvement showed small-to-moderate effect sizes that were fairly robust to 
mild publication bias. Finally, the epilepsy group with primarily direct CNS involvement (e.g., 
epileptic electrochemical activity) showed the largest effect size and had the results most robust 
to any publication bias.  
 Nonetheless, the findings suggest a generalist view could have some applicability to 
clinical understanding of the larger pediatric population. While there appears to be variability to 
the severity of the EF deficits, and which EF skills are implicated, pediatric youth with chronic 
medical conditions are at increased risk of EF deficits. This knowledge can be used to help 
inform clinical care with this population, including formulation of treatment adherence supports 
and psychoeducation for patients and families. For example, mobile phone applications exist that 
assist patients with reminders to engage in tasks related to their treatment regimen (e.g., taking a 
26 
medication, using a nebulizer), and additional tools could potentially be created that work for 
pediatric youth more broadly. 
 A noteable overall finding is that reports on questionnaires (primarily via parent-report) 
seem to highlight EF deficits as much as (and somewhat moreso than) performance-based 
measures. While referring every patient for a neuropsychological assessment is not feasible, nor 
necessarily indicated in all cases, these questionnaires may be beneficial for including regularly 
in pediatric care for chronic medical conditions. Doing so, along with a thorough interview with 
patients and families, may help to distinguish between patients with more severe EF deficits and 
those without. This identification could allow for appropriate treatment, and thus higher 
likelihood of good long-term outcomes in terms of adaptive functioning, academic achievement, 
employment, and so forth (e.g., Best et al., 2011; J. Biederman et al., 2007; Brock et al., 2009). 
Strengths 
The current study has several key strengths. First, the use of Google Scholar allowed for 
wide-spread searching across a diverse population of patients (e.g., studies in Korea and Ghana, 
journals in multiple disciplines). Second, the strategies used for the literature review (i.e., 
preliminary search, examination of references, forward citation search) helped to ensure a 
relatively exhaustive collection of publications. Third, this study is unique in its comparison 
across pediatric chronic medical conditions, widening its applicability to the field and 
highlighting commonalities in the experiences of these pediatric youth that are generally 
understudied. 
Limitations 
Despite its strengths, the current study also has a number of limitations. First, the analysis 
was conducted with only a small subset of the overall pediatric population. It would be helpful 
27 
for a more comprehensive meta-analysis to be conducted to see if the same findings generalize 
across additional conditions.  
Second, there was limited ability for the current study to examine within-group variance. 
Future research should attempt to examine various subsets of pediatric populations (e.g., poor vs. 
good glycemic control, solid vs. blood cancer, type of seizure) to see if EF deficits appear stable 
across subgroups or if they are associated with specific types of complications/treatments. While 
this has been done in individual studies of these populations, not all publications present 
information in a way that allows for consistent and meaningful grouping of subsets of 
participants in this way.  
Third, many of the results are based on measures that are currenly considered out-dated. 
This is in part due to the lack of a clear time cutoff to use for a meta-analysis of EF, meaning 
some older studies will inherently meet inclusion criteria. However, there is also a time gap 
between EF assessment batteries being updated and released for clinical use, and their emergence 
in the broader research literature. For example, the BRIEF-2 (Isquith, Gioia, Guy, & Kenworthy, 
2015) is in widespread use for clinical work at the time of this study and includes changes to the 
division of EF skills, but the original BRIEF (Gioia et al., 2000) was almost exclusively 
represented in the literature at the time of our search. Fortunately, new studies on this topic are 
being published frequently, which means more thorough meta-analyses with more recent (and 
theoretically improved) measures can be done in the near future. 
Fourth, not all EF skills are equally represented in this body of literature (e.g., poor 
representation of initiation; see Table 1). While not assessed as part of the coding process, many 
of the eligible articles utilized batteries that included EF as a component (e.g., the Working 
Memory Index on Wechsler scales; e.g., Wechsler, 2003). However, specific measures were also 
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selected (e.g., Wisconsin Card Sorting Task; Heaton, 1981), potentially as a result of biases 
researchers hold regarding what EF skills will be most implicated in a population. Future studies 
should seek to include more extensive batteries of EF skills in these pediatric youth to help 
insure deficits are not overlooked. 
Fifth, only a minority (30%) of publications reported information on race/ethnicity of 
their samples, with more detailed demographic information (e.g., SES) even less represented in 
the literature. Therefore, it is unclear to what extent these results could be attributed to factors 
such as SES, which has been linked to both lower EF (e.g., Sarsour et al., 2011) and higher rates 
of experienced chronic medical conditions (e.g., obesity; Jin & Jones-Smith, 2015). Future 
studies should make an effort to collect and report more of this crucial information.  
Finally, the current study was unable to assess for overall quality of the publications (e.g., 
via the Grading of Recommendations, Assessment, Development and Evaluation [GRADE; 
Balshem et al., 2011)] system) due to the wide variability within the represented literature (e.g., 
baseline measurements in medication trials, single timepoints in longitudinal observation studies, 
single studies using convenience sampling). Future studies on this topic will benefit from 
identification of a system for determining study rigor/quality (e.g., determining appropriate 
sampling strategies for representative samples of pediatric youth). Unfortunately, there is no way 
to know by simply looking at a publication whether or not the measures were administered and 
scored properly, which is likely the most relevant quality factor in this type of meta-analysis.  
Future directions 
As research into EF in pediatric populations continues to move forward, there is also a 
need to consider clinical implications. Executive coaching is sometimes utilized within therapy, 
though the efficacy of this treatment is unclear. Cognitive remediation with pediatric youth has 
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been assessed in the literature, including an intervention with proven efficacy demonstrated by a 
randomized clinical trial (Butler et al., 2008; Butler & Copeland, 2002). However, such 
interventions are generally intensive and primarily focused on difficulties related to selective 
attention, suggesting there is room for improved efficiency and efficacy via direct targeting of a 
wider range of skills as appropriate. Part of the reason for limited research on treatment is likely 
again due to disagreements about what is considered an executive function, and thus what skills 
should be targeted. In addition, executive coaching with pediatric youth often needs to 
accommodate limitations related to a child’s medical condition (e.g., limited mobility), adding a 
layer of complexity. While the current study offers limited insight into these factors, it serves as 
evidence that future research into this area is warranted, and that these interventions are likely 
worth developing. 
In addition, more work is needed to understand how EF can be better assessed in the 
clinical setting. Assessing all domains that can be conceptually considered as EFs involves long 
measures (e.g., 63-item BRIEF-2; Isquith et al., 2015), which can be burdensome for young 
children and their parents. If screeners can be created to assess the most frequently impacted EF 
skills (similar to the screener available for the BRIEF-2, but tailored to pediatric youth), some of 
this burden can be reduced. Such a screener could also allow primary care physicians to 
administer it quickly during regular outpatient appointments, an approach that is increasingly of 
interest for providing care and identifying mental health needs in pediatric youth more 
consistently (e.g., Asarnow, Rozenman, Wiblin, & Zeltzer, 2015).   
Finally, these findings have implications for policy development, particularly in relation 
to schools. While pediatric youth are often able to receive modifications and accommodations as 
part of the Americans with Disabilities Act (ADA), it can sometimes be difficult for families to 
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navigate these policies that are already in place. This may be especially true for children who 
appear physically well, as has been reported on in post-concussion populations (Halstead et al., 
2013). If pediatric youth show patterns of reduced EF, this may help to explain changes in 
academic performance and thus can warrant appropriate tailoring of school curriculum and 
access to the needs of patients. With appropriate supports, these youth may be able to overcome 
difficulties related to EF, which could in turn potentially improve their academic performance. 
Based on the findings of this study, schools should consider adopting policies specifically related 
to pediatric youth, with some emphasis on helping to support executive functioning 
development. Doing so can help to ensure appropriate modifications and accommodations that 
can be more consistently applied and in compliance with existing ADA policies. 
Summary 
EF skills are important for long-term outcomes in youth generally. Pediatric youth, with 
varying degrees of alterations to their CNS and often pervasive changes to their socioecological 
relationships and exposures, are at heightened risk of EF deficits. This meta-analysis found 
evidence to support this idea that pediatric youth with a chronic medical condition perform worse 
on tasks of EF overall compared to healthy peers, with a pattern of worse performance as the 
CNS is more directly involved. This highlights the need for further study of EF in these 
populations, further study of common challenges across pediatric conditions, and exploration 
into clinical interventions that may be feasible and efficacious to boost EF in these populations.  
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Figure 1. Conceptual Model of EF in Pediatric Youth   
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1. ("executive functioning" OR "executive functions”) OR ((inhibition OR "effortful 
control") OR switching OR ("working memory" OR updating) OR "selective attention" 
OR planning OR organizing 
2. (pediatric OR youth OR children OR adolescents) AND (("executive functioning" OR 
"executive functions) OR ((inhibition OR "effortful control") OR switching OR 
("working memory" OR updating) OR "selective attention" OR planning OR organizing)) 
3. pediatric AND ("executive functioning" OR "executive functions") 
4. “child diabetes” AND “executive functioning” 
5. juvenile diabetes executive functioning 
6. child diabetes working memory 
7. “child diabetes” AND attention 
8. child diabetes selective attention 
9. (pediatric OR child) AND cancer AND “executive functioning” 
10. (pediatric OR child) AND cancer AND neurocognitive 
11. (pediatric OR child) AND cancer AND (attention OR “working memory”) 
12.  (pediatric OR child) AND (epilepsy OR seizure) AND “executive functioning” 
13. (pediatric OR child) AND (epilepsy OR seizure) AND neurocognitive 
14. pediatric diabetes neurocognitive 
15. pediatric epilepsy neurocognitive 
16. pediatric cancer neurocognitive 
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1. Date coded 
2. Coder initials 
3. Study identification 
a. Study ID 
b. Study title 
c. Study authors 
d. Study year 
e. Study format 
i. Journal article 
ii. Book/chapter 
iii. Thesis/dissertation 
iv. Other/unpublished 
4. Sample information 
a. Sample size (overall) 
b. Age mean (in years) 
c. Age standard deviation (in years) 
d. Age (lowest, in years) 
e. Age (highest, in years) 
f. Percent of overall sample that is female 
g. Percent of overall sample that is part of an ethnic minority group 
h. Form of control group 
i. Healthy control group 
ii. Standardized norms 
46 
5. Assessments used 
a. Boston naming 
b. BRIEF 
c. Cancellation 
d. CBCL 
e. FAS 
f. Finger tapping 
g. McCarthy Scale 
h. Peabody achievement 
i. Grooved pegboard 
j. PPVT 
k. Rey Complex Figure Task 
l. Rapid naming 
m. Stanford-Binet 
n. Trail making 
o. Vineland 
p. VMI 
q. Wisconsin Card Sort 
r. WISC 
i. -R 
ii. -III 
s. Woodcock-Johnson 
i. -R 
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t. WPPSI 
i. -R 
u. WRAML 
v. WRAT 
i. -R 
w. Other (e.g., NEPSY, D-KEFS, WISC-IV) 
6. Medical condition(s) 
a. Cancer 
b. Diabetes 
c. Epilepsy 
7. Statistics reported (separate entries for each measure) 
a. t-value (if appropriate) 
b. p-value (if appropriate) 
c. Cohen’s d (if appropriate) 
d. Measure 
e. Subtest/Subscale name 
f. Means, SD, cell size 
i. Separate for illness group and healthy controls 
  
48 
 
 
 
 
 
Appendix D. Figures and Tables for Results 
  
49 
 
Figure 2. Literature search process.  
Final eligible
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128
Epilepsy = 
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Diabetes = 
32
Secondary reference search (backward and 
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+339
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+488
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Epilepsy = 
325
Diabetes = 
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Figure 3. Reasons for ineligibility. 
Note. n represents number of publications deemed ineligible for each reason.  
No measure of EF (n = 311)
Adults in sample (n = 320)
Review of literature (n = 354)
Missing scores (n = 129)
Overlap in sample (n = 77)
No normative data available (n = 25)
Not in English (n = 3)
Other (e.g., proposal, rat study; n = 42)
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Figure 4. Funnel Plot for Overall Database 
 
 
 
Figure 5. Funnel Plot for Cancer/Tumor Publications 
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Figure 6. Funnel Plot for Epilepsy/Seizure Publications 
 
 
 
Figure 7. Funnel Plots for Diabetes Publications 
Note: Plot for all diabetes comparisons on the left; plot for planning/organization comparisons 
on the right.  
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Table 1. Hedges’s g Scores by Group and EF Skill 
 
EF Skill 
 
Diabetes 
 
Cancer/Tumor 
 
Epilepsy 
 
Inhibition 
 
0.008 
(n = 18) 
 
-0.176*** 
(n = 117) 
 
-0.471*** 
(n = 194) 
 
Attention 
 
0.126 
(n = 16) 
 
-0.494*** 
(n = 113) 
 
-0.614*** 
(n = 175) 
 
Planning/Organization 
 
-0.780** 
(n = 25) 
 
-0.511*** 
(n = 110) 
 
-0.461*** 
(n = 156) 
 
Switching 
 
-0.089 
(n = 15) 
 
-0.314*** 
(n = 118) 
 
-0.429*** 
(n = 109) 
 
Self-Monitor 
 
0.207 
(n = 6) 
 
-0.417*** 
(n = 40) 
 
-1.120*** 
(n = 32) 
 
Working Memory/ 
Sequencing 
 
-0.237 
(n = 21) 
 
-0.473*** 
(n = 170) 
 
-0.652*** 
(n = 131) 
 
Initiate 
 
 
-0.296 
(n = 2) 
 
 
-0.509*** 
(n = 16) 
 
-0.872*** 
(n = 10) 
Note. *p < 0.05; **p < 0.01; ***p < 0.001; n represents number of comparisons between ill 
participants and controls for each skill; values based on random effects model. 
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Table 2. Hedges’s g by Moderator Level 
  
Hedges’s g 
 
95% CI 
 
Measure Type 
  
 
   Performance-based (n = 1152) 
 
-0.437*** 
 
-0.476, -0.399 
 
   Questionnaire (n = 478) 
 
-0.554*** 
 
-0.613, -0.495 
 
Control Type 
  
 
   Included healthy controls (n = 685) 
 
-0.427*** 
 
-0.476, -0.377 
 
   Norms-based pseudo-controls (n = 945) 
 
-0.503*** 
 
-0.545, -0.460 
 
Publication Format 
  
 
   Journal article (n = 1453) 
 
-0.464*** 
 
-0.499, -0.429 
 
   Thesis/Dissertation (n = 164) 
 
-0.543*** 
 
-0.628, -0.458 
 
   Other (n = 13) 
 
 
-0.667*** 
 
-0.839, -0.496 
Note. *p < 0.05; **p < 0.01; ***p < 0.001; n represents the number of comparisons between ill 
participants and controls for each format; values based on random effects model. 
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Table 3. Hedges’s g by Condition and Data Source 
 
Illness Group 
 
Performance-Based 
 
Questionnaire 
 
Diabetes 
 
-0.398*** 
 
-0.135 
 
Cancer/Tumor 
 
-0.385*** 
 
-0.453*** 
 
Epilepsy/Seizures 
 
 
-0.478*** 
 
-0.796*** 
Note. All g values are based on overall results for each medical condition group; *p < .05; **p < 
.01; ***p < .001.  
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Table 4. Orwin’s Failsafe N’s by Illness Group 
 
Illness Group 
 
Failsafe N* 
 
Diabetes** 
 
23 
 
Cancer/Tumor 
 
414 
 
Epilepsy/Seizure 
 
 
1,552 
Note. *Calculated based on number of comparisons needed with Hedges’s g = 0 to fall below an 
overall effect size of 0.2; **Calculated for the planning/organization publications only with 
threshold of 0.1 instead of 0.2; values based on fixed effects model. 
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 -0.540 
 
Kolk et al. (2001) 
 
44 
 
6.57 
 
50 
 
- 
 
NEPSY10 
 
 -0.910 
 
Koop et al. (2005) 
 
95 
 
10.41 
 
48 
 
6 
 
CPTb39 
 
ACT78 
 
 0.780 
 
Kral et al. (2016) 
 
204 
 
11.23 
 
47 
 
- 
 
WISC-IV23 
 
WAIS-IV24 
 
CPT-II29 
 
BASC-233 
 
BRIEF2 
 
 -1.192 
 
Kral et al. (2017) 
 
20 
 
8.26 
 
50 
 
- 
 
Conners 337 
 
 -2.996 
 
Lee et al. (2018) 
 
40 
 
7.70 
 
75 
 
- 
 
Advanced Test of 
Attention (ATA)79 
 
ADHD Rating Scale 
(ARS)20 
 
 -0.535 
 
Lee et al. (2015) 
 
55 
 
10.77 
 
47 
 
- 
 
WISC-III18 
 
S-CWT19 
 
TMT3 
 
 -0.318 
 
Levan (2015) 
 
28 
 
11.79 
 
50 
 
36 
 
BRIEF2 
 
 -1.172 
 
Lima et al. (2014) 
 
62 
 
10.40 
 
- 
 
- 
 
WISC-III18 
 
WCST6 
 
 -0.246 
124 
 
Lima et al. (2017) 
 
60 
 
11.52 
 
58 
 
- 
 
WISC-III18 
 
WISC-IV23 
 
TMT3 
 
WCST6 
 
 -0.383 
 
Lin et al. (2012) 
 
67 
 
12.62 
 
52 
 
- 
 
D-KEFS9 
 
BRIEF2 
 
 -0.722 
 
Liu et al. (2011) 
 
122 
 
10.18 
 
38 
 
- 
 
WISC-III18 
 
CPT-II29 
 
 -0.182 
 
Lopes et al. (2013) 
 
120 
 
9.99 
 
53 
 
- 
 
WISC-III18 
 
 -1.029 
 
Lordo et al. (2017) 
 
207 
 
10.60 
 
45 
 
19 
 
BASC-233 
 
Children’s Memory 
Scale (CMS)80 
 
 -0.789 
 
Love et al. (2016) 
 
54 
 
11.59 
 
48 
 
30 
 
BRIEF2 
 
WISC-IV23 
 
Wechsler 
Abbreviated Scale of 
Intelligence – 2nd 
Edition (WASI-II)81 
 
 -0.928 
 
Lundmark (2010) 
 
42 
 
12.65 
 
57 
 
- 
 
BRIEF2 
 
 -0.577 
 
Luton et al. (2010) 
 
40 
 
12.55 
 
35 
 
42 
 
D-KEFS9 
 
BRIEF2 
 
 -1.443 
 
MacAllister et al. (2012) 
 
90 
 
12.36 
 
46 
 
- 
 
ToL5 
 
BRIEF2 
 
 -0.831 
 
Mankinen et al. (2014) 
 
42 
 
11.70 
 
52 
 
- 
 
WISC-III18 
 
 0.000 
 
Masur et al. (2013) 
 
446 
 
- 
 
- 
 
- 
 
WISC-IV23 
 
WCST6 
 
 -0.339 
 
Modi et al. (2017) 
 
11 
 
15.17 
 
73 
 
- 
 
BRIEF2 
 
 -0.262 
 
Modi et al. (2018) 
 
38 
 
15.30 
 
71 
 
13 
 
BRIEF2 
 
D-KEFS9 
 
TEA-CH31 
 
 -0.013 
125 
 
CBCL8 
 
WAIS-IV24 
 
Wechsler 
Intelligence Scale 
for Childre – 5th 
Edition (WISC-V)82 
 
National Institutes of 
Health Toolbox 
(NIH Toolbox)83 
 
Myatchin & Lagae (2011) 
 
62 
 
9.90 
 
- 
 
- 
 
Backmatching* 
 
 -0.286 
 
Neri et al. (2012) 
 
53 
 
10.69 
 
43 
 
- 
 
WCST6 
 
 -0.909 
 
Nicolai et al. (2012) 
 
229 
 
10.11 
 
45 
 
- 
 
FePsy65 
 
 -0.365 
 
Nissenkorn et al. (2017) 
 
34 
 
6.24 
 
59 
 
- 
 
WISC-IV23 
 
CPT-II29 
 
 -0.124 
 
Northcott et al. (2005) 
 
42 
 
8.50 
 
38 
 
- 
 
WISC-III18 
 
ROCFT14 
 
TMT3 
 
Wide Range 
Assessment of 
Memory and 
Learning 
(WRAML)84 
 
 -0.336 
 
Ofer et al. (2018) 
 
10 
 
9.76 
 
40 
 
- 
 
WISC-IV23 
 
 0.325 
 
O’Leary et al. (1983) 
 
106 
 
12.44 
 
- 
 
- 
 
CCT55 
 
TMT3 
 
 0.048 
 
Oostrom et al. (2002) 
 
99 
 
10.00 
 
- 
 
- 
 
CCTT58 
 
 -0.171 
 
Papazoglou (2009) 
 
62 
 
11.64 
 
- 
 
- 
 
BRIEF2 
 
 -0.723 
 
Parisi et al. (2012) 
 
32 
 
11.60 
 
44 
 
- 
 
WISC-III18 
 
NEPSY – 2nd Edition 
(NEPSY-2)85 
 
 -1.069 
 
Parrish et al. (2007) 
 
103 
 
12.70 
 
48 
 
- 
 
BRIEF2 
 
D-KEFS9 
 
 -0.618 
 
Piccinelli et al. (2010) 
 
43 
 
10.40 
 
51 
 
- 
 
WCST6 
 
 -0.144 
126 
 
Pinton et al. (2006) 
 
18 
 
6.67 
 
39 
 
- 
 
Battery for Rapid 
Evaluation of 
Cognitive Functions 
(BREV)86 
 
 -0.558 
 
Posar et al. (2014) 
 
10 
 
10.67 
 
60 
 
- 
 
WISC-R12 
 
ROCFT14 
 
FePsy65 
 
 -1.598 
 
Pulsipher et al. (2009) 
 
83 
 
13.33 
 
53 
 
- 
 
BRIEF2 
 
 -0.281 
 
Rantanen et al. (2010) 
 
26 
 
4.98 
 
54 
 
- 
 
NEPSY10 
 
 -0.676 
 
Raud et al. (2015) 
 
65 
 
10.37 
 
55 
 
- 
 
NEPSY10 
 
 -0.735 
 
Riccio et al. (2015) 
 
28 
 
12.88 
 
29 
 
32 
 
WCST6 
 
ROCFT14 
 
CMS80 
 
 -0.296 
 
Riva & Devoti (1999) 
 
7 
 
13.67 
 
- 
 
- 
 
WISC-R12 
 
 -0.667 
 
Riva et al. (2002) 
 
8 
 
- 
 
63 
 
- 
 
WCST6 
 
CVLT-C49 
 
 -0.893 
 
Riva et al. (2007) 
 
40 
 
9.65 
 
33 
 
- 
 
WISC-R12 
 
 -0.640 
 
Rzezak et al. (2012) 
 
64 
 
11.86 
 
41 
 
- 
 
WISC-III18 
 
TMT3 
 
WCST6 
 
WRAML84 
 
 -0.506 
 
Sarhan et al. (2015) 
 
50 
 
8.70 
 
36 
 
- 
 
CBCL8 
 
 -3.158 
 
Sart et al. (2006) 
 
60 
 
10.80 
 
30 
 
- 
 
WISC-R12 
 
 -0.637 
 
Schmidt et al. (2015) 
 
15 
 
13.10 
 
53 
 
- 
 
WISC-IV23 
 
ROCFT14 
 
 -0.964 
 
Schoenfeld et al. (1999) 
 
84 
 
11.07 
 
62 
 
- 
 
TMT3 
 
S-CWT19 
 
 -0.140 
 
Schouten et al. (2002) 
 
135 
 
9.10 
 
53 
 
- 
 
Word Span* 
 
 -0.400 
 
Schouten et al. (2000) 
 
64 
 
7.20 
 
- 
 
- 
 
Sorting Task for 
Children (STC)* 
 
 -0.575 
127 
 
Schouten et al. (2009) 
 
62 
 
9.48 
 
45 
 
- 
 
ROCFT14 
 
 -0.896 
 
Schraegle & Titus (2016) 
 
130 
 
11.50 
 
44 
 
38 
 
BRIEF2 
 
 -1.065 
 
Scott (2013) 
 
15 
 
8.67 
 
47 
 
- 
 
WISC-IV23 
 
 -0.106 
 
Seidel & Mitchell (1999) 
 
10 
 
9.70 
 
40 
 
- 
 
CAT76 
 
TMT3 
 
 -0.695 
 
Seidenberg et al. (1988) 
 
48 
 
12.14 
 
52 
 
- 
 
TMT3 
 
Wechsler Memory 
Scale (WMS)87 
 
 0.050 
 
Selassie et al. (2008) 
 
20 
 
6.50 
 
70 
 
- 
 
NEPSY10 
 
 -0.119 
 
Sepeta et al. (2017) 
 
140 
 
10.25 
 
43 
 
- 
 
WISC-IV23 
 
BRIEF2 
 
CVLT-C49 
 
 -0.367 
 
Sherman et al. (2010) 
 
208 
 
11.30 
 
- 
 
- 
 
ADHD-RS-IV20 
 
 -0.501 
 
Sherman et al. (2012) 
 
212 
 
11.00 
 
57 
 
32 
 
WISC-IV23 
 
 -1.073 
 
Sibilia et al. (2017) 
 
45 
 
8.84 
 
- 
 
- 
 
ROCFT14 
 
 -0.756 
 
Singhi et al. (1992) 
 
80 
 
9.96 
 
36 
 
- 
 
WISC-R12 
 
 -0.805 
 
Smith et al. (2012) 
 
24 
 
11.06 
 
42 
 
- 
 
Integrated 
Continuous 
Performance Task* 
 
 0.147 
 
Smith et al. (2004) 
 
51 
 
13.22 
 
49 
 
- 
 
WISC-III18 
 
GDS7 
 
 -0.209 
 
Srnka et al. (2018) 
 
226 
 
12.02 
 
53 
 
- 
 
CPT-II29 
 
 -0.297 
 
Stefanatos (2015) 
 
51 
 
11.92 
 
29 
 
- 
 
BRIEF2 
 
WISC-IV18 
 
CBCL7 
 
 -1.240 
 
Tian et al. (2010) 
 
74 
 
11.40 
 
47 
 
- 
 
ANTb42 
 
 -0.158 
 
Triplett & Asato (2015) 
 
38 
 
12.40 
 
50 
 
18 
 
CNS Vital Signs 
(CNSVS)88 
 
 -0.584 
 
Tsai et al. (2013) 
 
183 
 
9.86 
 
38 
 
- 
 
CBCL8 
 
SNAP-IV72 
 
 -0.573 
128 
 
Tsai et al. (2015) 
 
101 
 
8.41 
 
- 
 
- 
 
WISC-IV23 
 
CPT-II29 
 
 -0.371 
 
Vago et al. (2008) 
 
40 
 
9.65 
 
33 
 
- 
 
CVLT-C49 
 
 -0.798 
 
van Mil et al. (2008) 
 
68 
 
10.25 
 
41 
 
- 
 
FePsy65 
 
ROCFT14 
 
 -0.193 
 
Veenstra et al. (2016) 
 
52 
 
12.62 
 
58 
 
69 
 
WISC-IV23 
 
TMT3 
 
 -1.035 
 
Vermeulen et al. (1994) 
 
165 
 
10.12 
 
47 
 
- 
 
WISC-R12 
 
FePsy65 
 
 -0.312 
 
Verrotti et al. (2013) 
 
35 
 
7.75 
 
43 
 
- 
 
WISC-IV23 
 
NEPSY-285 
 
 -1.439 
 
Vintan et al. (2012) 
 
36 
 
8.55 
 
- 
 
- 
 
Computerized 
Battery Tests 
(CANTAB)* 
 
 -0.073 
 
Wannag et al. (2010) 
 
46 
 
10.70 
 
- 
 
- 
 
Conners-R61 
 
 -1.323 
 
Weglage et al. (1997) 
 
80 
 
8.50 
 
43 
 
- 
 
CBCL8 
 
 -0.415 
 
Williams et al. (2002) 
 
42 
 
10.33 
 
52 
 
76 
 
Attention Deficit 
Disorders Evaluation 
Scale – Home 
Version (ADDES-
HV)89 
 
 -0.496 
 
Williams et al. (1996) 
 
84 
 
10.08 
 
50 
 
19 
 
WISC-R12 
 
 -0.567 
 
Wirrell et al. (2008) 
 
6 
 
9.10 
 
17 
 
- 
 
WISC-III18 
 
BRIEF2 
 
 -0.811 
 
Yang et al. (2015) 
 
180 
 
8.48 
 
37 
 
- 
 
ANTb42 
 
 -0.096 
 
Zeng (2017) 
 
209 
 
10.72 
 
47 
 
- 
 
WISC-IV23 
 
D-KEFS9 
 
NEPSY-285 
 
 -0.710 
 
Zilli et al. (2015) 
 
 
23 
 
9.80 
 
48 
 
- 
 
NEPSY-285 
 
 -0.441 
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Note. Age is represented in years; measures listed are only those included in the analyses; full 
name for measures are used the first time they are listed in the table, acronyms are used 
thereafter; not all subtests of test batteries were always included in publications or entered in 
analyses, but only the main measure names are listed in the table for brevity; g values based on 
mixed model, with all measurements for each study combined; references for the measures are 
listed below; *see source publication for description of measure. 
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